Kick-off for the Innovative "TheraMe!" Innosuisse project
— The laboratory of Biomedical Microfluidics (LBMM) was awarded with an Innosuisse grant, which started on August 1st 2021. The project "TheraMe! – Microfluidic IVD for personalized cancer therapy" is an 18 month ambitious and innovative project in personalized medicine, which aims to exploit microfluidic screening technology to guide clinical decision making. The platform will deliver prioritized treatment options within 24h after taking biopsies, at consumables costs of less than 150 US$.